Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 6;12(7):2735.
doi: 10.3390/jcm12072735.

Comparison of the Administration Route of Stem Cell Therapy for Ischemic Stroke: A Systematic Review and Meta-Analysis of the Clinical Outcomes and Safety

Asra Al Fauzi  1 , Ahmad Muslim Hidayat Thamrin  1 , Andhika Tomy Permana  1 , I G M Aswin R Ranuh  1 , Hanik Badriyah Hidayati  2 , Muhammad Hamdan  2 , Joni Wahyuhadi  1 , Nur Setiawan Suroto  1 , Pudji Lestari  3 , Poodipedi Sarat Chandra  4
Affiliations
Review

Comparison of the Administration Route of Stem Cell Therapy for Ischemic Stroke: A Systematic Review and Meta-Analysis of the Clinical Outcomes and Safety

Asra Al Fauzi et al. J Clin Med. .

Abstract

Stem cell treatment is emerging as an appealing alternative for stroke patients, but there still needs to be an agreement on the protocols in place, including the route of administration. This systematic review aimed to assess the efficacy and safety of the administration routes of stem cell treatment for ischemic stroke. A systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. A comprehensive literature search was undertaken using the PubMed, Scopus, and Cochrane databases. A total of 21 publications on stem cell therapy for ischemic stroke were included. Efficacy outcomes were measured using the National Institutes of Health Stroke Scale (NIHSS), the modified Rankin Scale (mRS), and the Barthel index (BI). Intracerebral administration showed a better outcome than other routes, but a greater number of adverse events followed due to its invasiveness. Adverse events were shown to be related to the natural history of stroke not to the treatment. However, further investigation is required, since studies have yet to compare the different administration methods directly.

Keywords: administration route; adverse events; ischemic stroke; outcome; stem cell therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines flowchart.
Figure 2
Figure 2
Forest Plot for the Risk of Adverse Events in Stem Cell Therapy [12,14,19,21,26,29,30,32].
Figure 3
Figure 3
Forest Plot for the Risk of Severe Adverse Events in Stem Cell Therapy [12,14,19,21,26,29,30,32].
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Bhatia V., Gupta V., Khurana D., Sharma R.R., Khandelwal N. Randomized Assessment of the Safety and Efficacy of Intra-Arterial Infusion of Autologous Stem Cells in Subacute Ischemic Stroke. Am. J. Neuroradiol. 2018;39:899–904. doi: 10.3174/ajnr.A5586. - DOI - PMC - PubMed
    1. Barthels D., Das H. Current Advances in Ischemic Stroke Research and Therapies. Biochim. Biophys. Acta Mol. Basis Dis. 2020;1866:165620. doi: 10.1016/j.bbadis.2018.09.012. - DOI - PMC - PubMed
    1. Steinberg G.K., Kondziolka D., Wechsler L.R., Lunsford L.D., Kim A.S., Johnson J.N., Bates D., Poggio G., Case C., McGrogan M., et al. Two-Year Safety and Clinical Outcomes in Chronic Ischemic Stroke Patients after Implantation of Modified Bone Marrow–Derived Mesenchymal Stem Cells (SB623): A Phase 1/2a Study. J. Neurosurg. 2019;131:1462–1472. doi: 10.3171/2018.5.JNS173147. - DOI - PubMed
    1. Wardlaw J.M., Murray V., Berge E., del Zoppo G.J. Thrombolysis for Acute Ischaemic Stroke. Cochrane Database Syst. Rev. 2014;2014:CD000213. doi: 10.1002/14651858.CD000213.pub3. - DOI - PMC - PubMed
    1. Powers W.J., Derdeyn C.P., Biller J., Coffey C.S., Hoh B.L., Jauch E.C., Johnston K.C., Johnston S.C., Khalessi A.A., Kidwell C.S., et al. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American. Stroke. 2015;46:3020–3035. doi: 10.1161/STR.0000000000000074. - DOI - PubMed

LinkOut - more resources